Form 4: Quest Diagnostics SVP Kuppusamy Reports Stock Transactions
SEC Form 4 Filing
Karthik Kuppusamy, SVP at Quest Diagnostics, reports acquisition and disposal of company stock, including dividend reinvestment and transactions within the company's stock purchase and 401(k) plans.
Summary
- Karthik Kuppusamy, a Senior Vice President at Quest Diagnostics, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On April 22, 2024, Kuppusamy acquired 45 shares of common stock through a dividend reinvestment plan at a price of $126.246 per share.
- Kuppusamy also reported 15,195 shares of common stock beneficially owned, which includes exempt purchases made under the company's stock purchase plan since the last Form 4 filing.
- Additionally, Kuppusamy reported indirect ownership of 358 shares held in a trust and 1,551 shares held in the company's 401(k) plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The filing primarily reports routine transactions related to dividend reinvestment and participation in company-sponsored plans. There's no indication of significant positive or negative sentiment from these transactions alone.
Positives
- The dividend reinvestment indicates Kuppusamy's continued investment in the company.
- Participation in the company's stock purchase plan suggests confidence in Quest Diagnostics' future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis.
- Comparing Kuppusamy's transactions to those of other executives at Quest Diagnostics and peer companies like Laboratory Corporation of America (Labcorp) can provide insights into relative sentiment.
- Analyzing the frequency and size of insider buys and sells relative to industry benchmarks can help assess whether the transactions are indicative of broader trends or company-specific factors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- Employees participating in the stock purchase plan are indirectly impacted by the company's stock performance.
Key Dates
| Date | Description |
|---|---|
| 04/22/2024 | Date of common stock acquisition through dividend reinvestment. |
| 04/26/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.